Dr Antje Behring, speaking at Health Technology Assessment World Europe 2011

Dr Antje Behring,
Officer, Pharmaceutical Department
Gemeinsamer Bundesausschuss

Dr. Antje Behring graduated with a PharmD and PhD in pharmaceutical science from the University of Munich, Germany. After working as consulting pharmacist for a German health insurance company, she joined Germany’s Federal Joint Committee (Gemeinsamer Bundesausschuss) Pharmaceuticals Department. Since then she has been involved in introduction of the procedure for additional benefit assessments for new pharmaceutical products and is responsible for handling incoming dossiers and requests for consultation meetings with pharmaceutical companies concerning the additional benefit assessment.

Appearing:

Day One – Wednesday 30 November 2011

12.25pm

Early advice by the Federal Joint Committee / Cooperation with German Drug regulatory bodies

• Early benefit assessment of new pharmaceuticals in Germany
• Requirements for the dossier
• Advice from G-BA to pharmaceutical industry, cooperation with national regulatory bodies and EMA

Dr Antje Behring,

Officer, Pharmaceutical Department,
Gemeinsamer Bundesausschuss

12.45pm